Pharmacodynamics of evocalcet for secondary hyperparathyroidism in Japanese hemodialysis patients

BACKGROUND: This study investigated the pharmacokinetics, pharmacodynamics, and safety of multiple doses of evocalcet in Japanese secondary hyperparathyroidism (SHPT) patients receiving hemodialysis. METHODS: In this multicenter, open-label study, conducted between August 2013 and March 2014, 27 pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Shigematsu, Takashi, Shimazaki, Ryutaro, Fukagawa, Masafumi, Akizawa, Tadao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6510802/
https://www.ncbi.nlm.nih.gov/pubmed/30159688
http://dx.doi.org/10.1007/s10157-018-1635-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6510802/
https://www.ncbi.nlm.nih.gov/pubmed/30159688
http://dx.doi.org/10.1007/s10157-018-1635-6

Ejemplares similares